|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | ||
| Loss on disposal of property and equipment | ||
| Reserve for equipment and supplies | ||
| Provision for uncollectible accounts receivable | ||
| Amortization (accretion) of premiums (discounts) on securities, net | ||
| Interest paid-in-kind | ||
| Amortization of debt discounts and issuance costs | ||
| Share-based compensation expense | ||
| Non-cash lease expense | ||
| Deferred income tax expense | ||
| Change in fair value of warrant liabilities | ||
| Changes in operating assets and liabilities: | ||
| Disposable medical equipment supplies | ||
| Prepaid expenses and other current assets | ||
| Accounts receivable | ||
| Accounts payable | ||
| Accrued liabilities | ||
| Operating lease liabilities | ||
| Other long-term assets | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Purchases of property and equipment | ||
| Deposits for medical rental equipment | ||
| Refund of deposits for medical rental equipment | ||
| Investment in equity security | ||
| Purchase of marketable securities | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities | ||
| Proceeds from issuance of redeemable preferred stock | ||
| Proceeds from issuance of common stock | ||
| Proceeds from issuance of stock to non-controlling interest | ||
| Proceeds from capital contributions | ||
| Payments of IPO offering costs | ||
| Payment of equity issuance costs | ||
| Deemed dividend for payments to third party on behalf of shareholder | ||
| Proceeds from stock option exercises | ||
| Net cash provided by financing activities | ||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash | ||
| Beginning of period | ||
| End of period | ||
| Non-cash investing and financing activities: | ||
| Purchases of property and equipment in accrued liabilities and accounts payable | ||
| Exercise of liability classified warrant | ||
| Remeasurement of lease liability | ||
| Equity offering costs incurred but not yet paid | ||
| Deemed dividend for payments to third party on behalf of shareholder included in accrued liabilities and accounts payable | ||
| Issuance of warrants related to long term debt | ||
| Conversion of redeemable preferred stock into Common Shares on completion of IPO | ||
| Supplemental disclosure of cash flow information | ||
| Income taxes paid | ||
| Interest paid | ||
| Cash and cash equivalents | ||
| Restricted cash |
Loading...
